References
- Saarinen U M. Severe infections in childhood leukemia. A follow-up study of 100 consecutive ALL patients. Acta Paediatr Scand 1984; 73: 515–522
- Peltola H, Salomaa T, Sivonen A, Renkonen O-V. Septicemia in a university pediatric hospital: A fiveyear analysis of the bacterial and fungal isolates and outcome of the infections. Scand J Infect Dis 1987; 19: 277–282
- Yost R L, Ramphal R. Ceftazidime review. Drug Intell Clin Pharm 1985; 19: 509–513
- Johnson D E, Thompson B, Calia F M. Comparative activities of piperacillin, ceftazidime, and amikacin, alone and in all possible combinations, against experimental Pseudomonas aeruginosa infections in neutropenic rats. Antimicrob Agents Chemother 1985; 28: 735–739
- de Pauw B E, Kauw F, Muytjens H, Williams K J, Bothof T. Randomized study of ceftazidime versus gentamicin plus cefotaxime for infections in severely granulocytopenic patients. J Antimicrob Chemother 1983; 12: 93–99, Suppl A
- Reilly J T, Brada M, Bellingham A J, Hart C A, Bennet C. Ceftazidime compared to tobramycin and ticarcillin in immunocompromised haematological patients. J Antimicrob Chemother 1983; 12: 89–92, Suppl A
- Clough J V, Farrell I D, Wood M J, Leyland M J. Ceftazidime plus mezlocillin as initial antibiotic therapy in febrile neutropenic patients with haematological malignancy. J Antimicrob Chemother 1985; 15: 353–363
- Kramer B S, Ramphal R, Rand K H. Randomized comparison between two ceftazidime-containing regimens and cephalothin-gentamicin-carbenicillin in febrile granulocytopenic cancer patients. Antimicrob Agents Chemother 1986; 30: 64–68
- Donnelly J P, Marcus R E, Goldman J M, Cohen J, Worsley A M, Catovsky D, Darrel J H, Want S V, Galton D A. Ceftazidime as first-line therapy for fever in acute leukaemia. J Infect 1985; 11: 205–215
- Darbyshire P J, Williamson P J, Pedler S J, Speller D C, Mott M G, Oakhill A. Ceftazidime in the treatment of febrile immunosuppressed children. J Antimicrob Chemother 1983; 12: 357–360, Suppl A
- Morgan G, Duerden B I, Lilleyman J S. Ceftazidime as a single agent in the management of children with fever and neutropenia. J Antimicrob Chemother 1983; 12: 347–351, Suppl A
- Granowetter L, Wells H, Lange B J. Ceftazidime with or without vancomycin vs cephalothin, carbenicillin and gentamicin as the initial therapy of the febrile neutropenic pediatric cancer patient. Pediatr Infect Dis 1988; 7: 165–170
- Ericsson H M, Sherris J C. Antibiotic sensitivity testing. Report of an international collaborative study. Acta Pathol Microbiol Scand (B) 1971, Suppl 217
- NCCLS. Performance standards for antimicrobial disc susceptibility tests, 3rd ed. October, 1983; M2–T3
- Gardner M J, Altman D G. Statistics with confidence. Confidence intervals and statistical guidelines. British Medical Journal, London 1989
- Bodey G B, Buckley M, Sathe Y S, Freireich E J. Quantitative relationship between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med 1966; 64: 328–340
- Johansson P JH, Ursing B. Infectious complications to granulocytopenia. Scand J Infect Dis 1984; 16: 361–367
- de Pauw B, Williams K, de Neeff J, Bothof T, de Witte T, Holdrinet R, Haanen C. A randomized prospective study of ceftazidime versus ceftazidime plus flucloxacillin in the empiric treatment of febrile episodes in severely neutropenic patients. Antimicrob Agents Chemother 1985; 28: 824–828
- Verhagen C S, de Pauw B, de Witte T, Janssen J, Williams K, de Mulder P, Bothof T. Randomized prospective study of ceftazidime versus ceftazidime plus cephalothin in empiric treatment of febrile episodes in severely neutropenic patients. Antimicrob Agents Chemother 1987; 31: 191–196